Evidence map›Paper›PMID 25220952›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2015

ASTM international workshop on standards and measurements for tissue engineering scaffolds.

Carl G Simon, Michael J Yaszemski, Anthony Ratcliffe, Paul Tomlins, Reto Luginbuehl, John A Tesk

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Standardised Matrices for Stem Cells.Advances in experimental medicine and biology · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Bioprinting and biomaterials for dental alveolar tissue regeneration.Frontiers in bioengineering and biotechnology · 2023
    Review
  11. Review
  12. Article
  13. Review
  14. Nanofiber scaffolds influence organelle structure and function in bone marrow stromal cells.Journal of biomedical materials research. Part B, Applied biomaterials · 2017
    Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carl G SimonBiosystems and Biomaterials Division, National Institute of Standards and Technology, Gaithersburg, Maryland.
Michael J YaszemskiDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
Anthony RatcliffeSynthasome, Inc., San Diego, California.
Paul TomlinsEuropean Standards Consultant, Egham, UK.
Reto LuginbuehlDepartment of Chemistry and Biology, RMS Foundation, Bettlach, Switzerland.
John A TeskBiomedical Materials and Devices Consulting, Highland, Maryland.

Funding

Intramural NIST DOC 9999-NIST
6 · The paper itself

Abstract

The "Workshop on Standards & Measurements for Tissue Engineering Scaffolds" was held on May 21, 2013 in Indianapolis, IN, and was sponsored by the ASTM International (ASTM). The purpose of the workshop was to identify the highest priority items for future standards work for scaffolds used in the development and manufacture of tissue engineered medical products (TEMPs). Eighteen speakers and 78 attendees met to assess current scaffold standards and to prioritize needs for future standards. A key finding was that the ASTM TEMPs subcommittees (F04.41-46) have many active "guide" documents for educational purposes, but few standard "test methods" or "practices." Overwhelmingly, the most clearly identified need was standards for measuring the structure of scaffolds, followed by standards for biological characterization, including in vitro testing, animal models and cell-material interactions. The third most pressing need was to develop standards for assessing the mechanical properties of scaffolds. Additional needs included standards for assessing scaffold degradation, clinical outcomes with scaffolds, effects of sterilization on scaffolds, scaffold composition, and drug release from scaffolds. Discussions highlighted the need for additional scaffold reference materials and the need to use them for measurement traceability. Workshop participants emphasized the need to promote the use of standards in scaffold fabrication, characterization, and commercialization. Finally, participants noted that standards would be more broadly accepted if their impact in the TEMPs community could be quantified. Many scaffold standard needs have been identified and focus is turning to generating these standards to support the use of scaffolds in TEMPs.

Indexed as

Tissue ScaffoldsAnimalsCongresses as TopicEducationHumansTissue EngineeringASTM Internationaldocumentary standardsreference materialstissue scaffoldworkshop report

Identifiers

PMID25220952
PMCPMC4886474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.